Uncategorized Archives - PulmCCM
Advertisement


Uncategorized Articles

Feb 262017
 
PulmCCM Partners With MedPage Today

Dear colleagues, Since 2012, PulmCCM has sought to bring you “all the best in pulmonary and critical care”: up-to-date, useful information in our specialties, presented in the most efficient way. To that end, I am pleased to announce a new partnership between PulmCCM and MedPage Today, the leading medical news service for health-care professionals. This relationship will [… read more]

Jan 112017
 
ICU Physiology in 1000 Words: Hidden Hemodynamics in Respiratory Mechanics

Jon-Emile S. Kenny MD [@heart_lung] Hemodynamic assessment, by any means, demands a shrewd familiarity with mechanical heart-lung interaction.  The two ventricles communicate in series and in parallel; each ventricle’s pressure-volume characteristics and loading conditions pulsate between systole and diastole.  And around the heart and pericardium lies the respiratory pump – the lungs within the thorax [… read more]

Jun 102016
 
Call for Abstracts: Pittsburgh-Munich International Lung Conference

Have you submitted your abstract to the 2016 Pittsburgh – Munich International Lung Conference? Concurrent submissions are accepted!  Use the abstracts you have submitted this spring for other national/international conferences (i.e. ATS) for a chance to further showcase your work.  Click on the links below to begin. The 2016 Pittsburgh – Munich International Lung Conference [… read more]

May 012016
 
ICU Physiology in 1,000 Words: ARDS - Part 2

Jon-Emile S. Kenny [@heart_lung] Gattinoni and Quintel have, very recently, outlined their approach to managing the acute respiratory distress syndrome [ARDS] [1].  They argue that treatment of ARDS should minimize firstly, the mechanical power applied to the lungs – as described in part 1.  Secondly, Gattinoni and Quintel note that, in the treatment of ARDS, [… read more]

Jun 252015
 
PulmCCM Journal Vol. 1, Issue 3 Now Available

Issue #3 of PulmCCM Journal, an open-access, peer-reviewed journal in pulmonary and critical care medicine, is now available online. Click the link, or the “Journal” tab in the menu bar on PulmCCM to read the latest issue of PulmCCM Journal. This issue’s featured concise clinical review is “Who should undergo intracranial pressure monitoring in acute liver failure?” by [… read more]

Apr 032014
 
FDA warns against doripenem (Doribax) for ventilator-associated pneumonia

FDA Warning on Doripenem (Doribax) for VAP In March 2014, the FDA issued a warning statement against Doribax (doripenem) for ventilator associated pneumonia, saying: Doribax carries an increased risk of death and lower clinical cure rates compared to use of imipenem and cilastatin … Doribax is not approved to treat any type of pneumonia. (Doripenem is approved [… read more]

Mar 252014
 

May 10th and 11th (pre-congress courses on may 9th), Montreal. Great speakers, great topics, great city, great weather (well…hopefully no snow!). Do you know how to use ultrasound to help you diagnose or manage coma, bowel obstruction, CHF, dyspnea, swollen joints and renal failure, among other things?  No matter how good you are at the [… read more]

Sep 122013
 
Join Us at the 2013 Pittsburgh International Lung Conference

We are quickly approaching the 2013 Pittsburgh International Lung Conference on October 17-18, 2013. The theme, “Acute and Chronic Lung Infections: Novel Pathogens, Diagnostics, and Therapeutics aims to describe and discuss the latest clinical and research advances as they apply to respiratory infections by bringing together leading regional, national, and international experts in the field. [… read more]

Sep 052013
 

Following “Surviving Sepsis” Guidelines Not Always the Best Care By Dr. Philippe Rola First of all, I would like to commend those involved in the Surviving Sepsis Campaign’s Guidelines. It is a tremendous endeavour that, without a doubt, has heightened awareness and their growing implementation has and will save many lives. I would, however, also [… read more]

Aug 032013
 
Riociguat improves chronic thromboembolic pulmonary hypertension (CTEPH)

Riociguat Improves Chronic Thromboembolic Pulmonary Hypertension (CTEPH): CHEST-1 Chronic thromboembolic pulmonary hypertension (CTEPH) is an uncommon complication of pulmonary embolism, in which the pulmonary blood vessels become occluded by the body’s ongoing reaction to residual blood clots. The result is slowly worsening shortness of breath, pulmonary hypertension, and eventually right heart failure. People with chronic [… read more]

Jun 152013
 
Thanks to everyone for your help.

The PulmCCM “Wall of Fame” THANKS to all of you who supported PulmCCM during the successful campaign to raise funding for development of high-quality iPhone and Android mobile apps. I really appreciate each and every one of your help (in chronological order): Anonymous Manish Aggarwal Lewis Satterwhite Robert Deutsch Mehdi Shelhamer Manuel Figueroa Mark Bloore [… read more]

Mar 312013
 
A New Way to Share: PulmCCM on Doximity

PulmCCM Debuts the New “Doximity Button” Are you on Doximity yet? It’s the brainchild of Internet health-tech visionary Nate Gross and the founders of Epocrates. It’s been called “Facebook for doctors,” but Doximity is more than that. It’s a protected, HIPAA-compliant online environment for physicians to communicate securely, and has the potential to change how we [… read more]